Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,421,000 | 2,137,000 | 1,435,000 | 596,000 | 510,000 |
| Marketable Securities | 308,000 | 248,000 | 148,000 | 1,362,000 | 1,772,000 |
| Receivables | 1,859,000 | 1,984,000 | 1,971,000 | 1,776,000 | 1,578,000 |
| Inventories | 1,322,000 | 1,490,000 | 1,451,000 | 1,366,000 | 1,139,000 |
| Other current assets | 660,000 | 762,000 | 562,000 | 570,000 | 553,000 |
| TOTAL | $6,570,000 | $6,621,000 | $5,567,000 | $5,670,000 | $5,552,000 |
| Non-Current Assets | |||||
| PPE Net | 3,374,000 | 3,141,000 | 2,936,000 | 2,631,000 | 2,350,000 |
| Other Non-Current Assets | 2,157,000 | 1,042,000 | 913,000 | 914,000 | 595,000 |
| TOTAL | $5,531,000 | $4,183,000 | $3,849,000 | $3,545,000 | $2,945,000 |
| Total Assets | $12,101,000 | $10,804,000 | $9,416,000 | $9,215,000 | $8,497,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 649,000 | 562,000 | 537,000 | 530,000 | 475,000 |
| Accrued Expenses | 1,550,000 | 1,422,000 | 1,167,000 | 1,354,000 | 1,414,000 |
| TOTAL | $3,065,000 | $3,300,000 | $2,752,000 | $2,821,000 | $2,659,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 588,000 | 176,000 | 135,000 | 231,000 | 237,000 |
| Other Non-Current Liabilities | 2,508,000 | 1,308,000 | 734,000 | 745,000 | 517,000 |
| TOTAL | $3,096,000 | $1,484,000 | $869,000 | $976,000 | $754,000 |
| Total Liabilities | $6,161,000 | $4,784,000 | $3,621,000 | $3,797,000 | $3,413,000 |
| Shareholders' Equity | |||||
| Common Shares | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 |
| Retained earnings | 7,243,000 | 6,769,000 | 6,235,000 | 5,428,000 | 4,796,000 |
| Other shareholders' equity | -332,000 | -208,000 | -90,000 | -61,000 | -149,000 |
| TOTAL | $5,940,000 | $6,020,000 | $5,795,000 | $5,418,000 | $5,084,000 |
| Total Liabilities And Equity | $12,101,000 | $10,804,000 | $9,416,000 | $9,215,000 | $8,497,000 |